Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
PUT
Royalty Pharma
RPRX
$26.1B
| $9.69M | ﹤0.01% |
193,500
+171,600
| +784% | +$7.28M |
|
2552
Archer Daniels Midland
ADM
$38.8B
| $9.67M | ﹤0.01% |
+191,820
| New | +$9.48M |
|
2553
Regenxbio
RGNX
$711M
| $9.67M | ﹤0.01% |
213,178
+144,118
| +209% | +$5.04M |
|
2554
CALL
Kinsale Capital Group
KNSL
$8.64B
| $9.67M | ﹤0.01% |
48,300
+30,900
| +178% | +$6.78M |
|
2555
Vanguard Morningstar Value ETF
VTV
$194B
| $9.66M | ﹤0.01% |
+81,234
| New | +$9.13M |
|
2556
CALL
Ares Capital
ARCC
$14.3B
| $9.66M | ﹤0.01% |
572,000
+7,000
| +1% | +$109K |
|
2557
Principal Financial Group
PFG
$24.4B
| $9.66M | ﹤0.01% |
194,651
+155,420
| +396% | +$7.12M |
|
2558
iShares Emerging Markets Equity Factor ETF
EMGF
$1.91B
| $9.65M | ﹤0.01% |
+196,523
| New | +$9.11M |
|
2559
Vanguard World Funds Extended Duration ETF
EDV
$3.45B
| $9.65M | ﹤0.01% |
63,376
-94,790
| -60% | -$15.1M |
|
2560
PUT
Polaris
PII
$3.95B
| $9.65M | ﹤0.01% |
101,300
+2,700
| +3% | +$258K |
|
2561
Steel Dynamics
STLD
$36.7B
| $9.65M | ﹤0.01% |
261,763
-566,222
| -68% | -$19.7M |
|
|
SIX
2562
CALL
DELISTED
Six Flags Entertainment Corp.
SIX
| $9.65M | ﹤0.01% |
283,000
-59,600
| -17% | -$1.63M |
|
|
GLS
2563
DELISTED
Gelesis Holdings, Inc.
GLS
| $9.64M | ﹤0.01% |
+950,000
| New | +$9.35M |
|
2564
PUT
FirstEnergy
FE
$27.4B
| $9.63M | ﹤0.01% |
314,600
-102,300
| -25% | -$3.07M |
|
2565
StoneCo
STNE
$2.32B
| $9.63M | ﹤0.01% |
114,716
+55,400
| +93% | +$3.71M |
|
2566
Cogent Biosciences
COGT
$6.58B
| $9.62M | ﹤0.01% |
856,942
+850,691
| +13,609% | +$9.35M |
|
2567
CALL
Lear
LEA
$8.32B
| $9.62M | ﹤0.01% |
60,500
+9,000
| +17% | +$1.27M |
|
2568
Main Street Capital
MAIN
$5.5B
| $9.62M | ﹤0.01% |
+298,076
| New | +$9.16M |
|
2569
NewMarket
NEU
$8.85B
| $9.62M | ﹤0.01% |
24,145
+4,698
| +24% | +$1.75M |
|
2570
CALL
iRhythm Holdings
IRTC
$4.17B
| $9.61M | ﹤0.01% |
40,500
+22,200
| +121% | +$5.06M |
|
2571
PUT
Ecolab
ECL
$77.4B
| $9.61M | ﹤0.01% |
44,400
-22,200
| -33% | -$4.64M |
|
2572
PUT
Annaly Capital Management
NLY
$17.6B
| $9.61M | ﹤0.01% |
284,200
-142,875
| -33% | -$4.42M |
|
2573
Ally Financial
ALLY
$13.7B
| $9.59M | ﹤0.01% |
269,042
-1,606,764
| -86% | -$48.6M |
|
2574
CALL
Rithm Capital
RITM
$5.79B
| $9.59M | ﹤0.01% |
964,900
+316,600
| +49% | +$2.8M |
|
|
CRHC
2575
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $9.59M | ﹤0.01% |
+921,053
| New | +$9.19M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.